Skip to main content
OpenTrials

Clinical trial condition

Urologic Diseases

Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.

13,603 public trials 2,148 recruiting studies
Refine in advanced search Browse all conditions

Urologic Diseases trial results

Active, Not Recruiting

A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis

NCT04221477

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • University of Alabama at Birmingham Medical Center Birmingham, Alabama, United States
  • Wallace Rheumatic Study Center Beverly Hills, California, United States
  • Kaiser Permanente - Fontana Fontana, California, United States
  • Kaiser Permanente - San Francisco Medical Center San Francisco, California, United States
View all 74 locations
View Trial Details
Active, Not Recruiting

Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

NCT02867592

Conditions
Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +92 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
View all 142 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

NCT04861259

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
Locations
  • Univ of CA San Francisco San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Emory Children's Center Atlanta, Georgia, United States
  • Washington University St Louis, Missouri, United States
View all 42 locations
View Trial Details
Active, Not Recruiting

Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease

NCT06747572

Conditions
Abnormalities, Multiple, Autosomal Dominant Polycystic Kidney Disease (ADPKD), Ciliopathies, +12 more
Locations
  • Alabama Kidney Research Alabaster, Alabama, United States
  • University of Alabama at Birmingham- Nephrology Research Clinic Birmingham, Alabama, United States
  • Kaiser Permanente - Los Angeles Medical Center Los Angeles, California, United States
  • UCLA Division of Nephrology Los Angeles, California, United States
View all 45 locations
View Trial Details
Active, Not Recruiting

Safety and Efficacy of Camrelizumab for High-risk NMIBC Failing BCG Treatment

NCT04706598

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Immunotherapy, +9 more
Locations
  • Shanghai Ninth People's Hospital,Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
  • Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
  • Shanghai Tenth People's Hospital,Shanghai Tong Ji University School of Medicine Shanghai, Shanghai Municipality, China
  • Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
View Trial Details
Active, Not Recruiting

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

NCT06383390

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +34 more
Locations
  • Alabama Kidney Research Alabaster, Alabama, United States
  • Central Research Associates Birmingham, Alabama, United States
  • Alliance for Multispecialty Research, LLC Daphne, Alabama, United States
  • Nephrology Consultants Huntsville, Alabama, United States
View all 743 locations
View Trial Details
Active, Not Recruiting

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

NCT06297603

Conditions
Chronic Disease, Diabetes Mellitus, Diabetes Mellitus, Type 2, +16 more
Locations
  • Nephrology Consultants Huntsville, Alabama, United States
  • Clinical Research Institute of Arizona (CRI) - Sun City West Sun City West, Arizona, United States
  • Kidney & Hypertension Center - Apple Valley Apple Valley, California, United States
  • Hope Clinical Research, Inc. Canoga Park, California, United States
View all 76 locations
View Trial Details

Related conditions